IVF Firm's $1.3M Crypto Gamble: XRP Flip, SOL Losses
Fertility clinic's crypto trading reveals $10,849 XRP profit but $1.58M unrealized SOL losses.
1Unusual Corporate Crypto Disclosure
Newgenivf Group, a Nasdaq-listed IVF provider with operations in Cambodia and Kyrgyzstan, revealed crypto trading activities in its amended SEC filing. The company purchased 146,432 XRP, 8.77 BTC, and 8.95 ETH during 2025 as part of treasury management, despite being primarily an IVF service provider. All positions except Solana were liquidated by year-end, with the XRP trade generating $10,849 profit. This disclosure stands out as one of the year's most unexpected corporate crypto revelations.
2XRP Round-Trip Trade Details
The fertility clinic's most notable crypto move involved buying 146,432 XRP tokens (worth approximately $73,216 at $0.50/XRP) and selling them all within 2025. This quick flip generated $10,849 in realized gains, contributing to total crypto profits of $942,915. Interestingly, the company emphasized these trades weren't part of core operations and didn't involve mining, staking, or accepting crypto payments from patients. The disclosure comes as XRP faces a 27% yearly decline despite recent ETF inflows exceeding $1.68 billion.
3Solana's Costly Hold Strategy
Newgenivf retained 13,000 SOL tokens valued at $1.63 million at year-end 2025, representing a $1.28 million unrealized loss from their $2.9 million cost basis. With SOL's price dropping to $101.69 currently, the loss has widened to $1.58 million. This positions the IVF provider among corporations like Forward Industries facing massive crypto losses. The SOL position alone turned the $942,915 realized gains into a $332,480 net crypto loss for the fiscal year.
4Bitcoin and Ethereum Trades
The company's crypto strategy included purchasing 8.77 BTC (worth ~$677,000 at current prices) and 8.95 ETH, both of which were completely sold during 2025. These trades contributed to the company's overall crypto gains but weren't individually detailed in the filings. The complete divestment contrasts with the decision to hold onto the losing SOL position, suggesting either a strategic hold or inability to exit profitably.
5Regulatory Context
The disclosures appear in an amended Form F-1/A filing with the SEC, typically used by companies preparing for public offerings. Newgenivf's crypto activities were documented under Note 8 of financial statements labeled 'digital assets.' The company took care to specify these were treasury management actions, not operational activities, potentially to avoid regulatory scrutiny about mixing healthcare services with speculative investments.
6Market Comparisons
Newgenivf's $1.58 million unrealized SOL loss mirrors struggles of other corporate crypto holders. Forward Industries, the largest corporate SOL holder, reportedly sits on over $1 billion in unrealized losses. The IVF provider's experience highlights risks of corporations dabbling in volatile crypto markets, especially when holding positions rather than quick trading. XRP's 27% annual decline further underscores market unpredictability.
7Ripple CTO's Optimistic Outlook
Despite XRP's struggles, Ripple's former CTO David Schwartz maintains bullish predictions, suggesting XRP could surpass Bitcoin in market capitalization. This contrasts with Newgenivf's decision to fully divest its XRP position. Schwartz's vision would require a 50x price increase from current levels, while the IVF company opted for quick profits rather than long-term bets, reflecting differing institutional versus developer perspectives on XRP's potential.
8Corporate Crypto Strategy Lessons
Newgenivf's crypto experiment offers cautionary insights for corporations considering digital assets. While the $10,849 XRP profit shows potential gains, the $1.58 million SOL loss demonstrates extreme volatility risks. The case raises questions about appropriate treasury management strategies for healthcare companies, particularly when nearly 170% of realized gains can be wiped out by a single held position. It also highlights disclosure challenges as crypto activities attract regulatory and investor scrutiny.
Original article: Bitcoin News — IVF Firm's $1.3M Crypto Gamble: XRP Flip, SOL Losses